Equius Partners, Inc.
- SEC CIK
- 0001911084
- Latest filing
- Jan 27, 2023
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 3, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 18
- +2 vs. Q2 2022
- Portfolio value
- $278.3M
- −$17.1M (−5.8%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| Dimensional ETF Trust25434V724 | US MKTWIDE VALUE | 3,028,591 | $89.7M | 32.2% | +36,370+1.2% | Added | – |
| Dimensional U.S. Targeted Value ETF25434V609 | ETF | 2,143,281 | $83.5M | 30.0% | −30,681−1.4% | Reduced | – |
| Dimensional ETF Trust25434V807 | INTERNATNAL VAL | 2,086,278 | $53.7M | 19.3% | +42,770+2.1% | Added | – |
| Dimensional ETF Trust25434V401 | US EQUI MARK ETF | 1,068,467 | $41.5M | 14.9% | −13,756−1.3% | Reduced | – |
| Dimensional U.S. Small Cap ETF25434V500 | ETF | 61,450 | $2.86M | 1.0% | −2,273−3.6% | Reduced | – |
| Dimensional ETF Trust25434V781 | INTL SMALL CAP V | 120,406 | $2.23M | 0.8% | +63,447+111.4% | Added | – |
| Dimensional ETF Trust25434V815 | US SMALL CAP ETF | 88,249 | $1.92M | 0.7% | +21,321+31.9% | Added | – |
| TWOU2U, LLC | COM | 130,720 | $817.0K | 0.3% | 00.0% | Unchanged | History |
| Dimensional ETF Trust25434V831 | US HIGH PROF ETF | 22,434 | $479.0K | 0.2% | +4,213+23.1% | Added | – |
| American Centy ETF Tr025072687 | AVANTIS SHFXDINC | 6,701 | $306.0K | 0.1% | −532−7.4% | Reduced | – |
| AAPLApple Inc. | Stock | 2,165 | $299.0K | 0.1% | +211+10.8% | Added | History |
| State Street SPDR Portfolio S&P 500 Growth ETF78464A409 | ETF | 5,340 | $268.0K | 0.1% | +5,340 | New | – |
| Invesco Exchange Traded FD T46137V464 | S&P MDCP MOMNTUM | 3,085 | $215.0K | 0.1% | +3,085 | New | – |
| GPGIGPGI, Inc. | COM CL A | 39,410 | $197.0K | 0.1% | −39,255−49.9% | Reduced | History |
| PTYPIMCO Corporate & Income Opportunity Fund | COM | 12,277 | $144.0K | 0.1% | +12,277 | New | History |
| NEUENeueHealth, Inc. | COM | 83,331 | $87.0K | <0.1% | 00.0% | Unchanged | History |
| KBNTKubient, Inc. | COM | 48,125 | $47.0K | <0.1% | 00.0% | Unchanged | History |
| APTOAptose Biosciences Inc. | COM NEW | 25,000 | $15.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2022 (1)
Positions held at the end of Q2 2022 that are gone from this filing.